Tagged With Medivation

A biotech CEO who sold his last company for $14 billion explains why he wants to do things differently this time

A company developing a drug to treat Alzheimer's disease just got a new CEO -- and the stock is jumping

Here's why Pfizer just spent $14 billion on a company with just one approved drug

BOUTIQUE BLOWOUT: 3 tiny firms will make a killing on a $14 billion pharma deal

Pfizer is buying cancer drugmaker Medivation for $14 billion

Pfizer is reportedly close to spending $14 billion on cancer drugmaker Medivation

This $10 billion drug maker is the hottest thing in the industry -- and it knows it

Medivation is reportedly exploring a sale -- and the stock is jumping

Why pharma giants are going after a relatively unknown cancer drugmaker

Here's why major drugmakers are going after a relatively unknown biotech

Medivation just rejected Sanofi's $9.3 billion takeover bid

There's a new multi-billion pound deal brewing in the pharma industry